JAZZ Jazz Pharmaceuticals plc - Ordinary Shares
NASDAQ · Pharmaceuticals · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q अग 3, 2026
$235.67
· 52 सप्ताह की सीमा का %
· निम्न से ऊपर
· उच्च तक
$128.8052w निम्न
$266.3852w उच्च
मार्केट कैप (MRQ)
$15.27B
P/E (TTM)
16.1
EPS (TTM)
$14.63
राजस्व (TTM)
$4.60B
आपके बैज
52W रेंज
$129–$266
विश्लेषक रेटिंग
BUY
मूल्य लक्ष्य
$294
P/E
16.1
ROE
22.1%
शुद्ध लाभ मार्जिन
20.4%
आपकी बैज स्ट्रिप खाली है — इस पेज पर कहीं भी एक मीट्रिक पिन करें।
JAZZ स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$235.67
मार्केट कैप (MRQ)
$15.27B
P/E (TTM)
16.1
EPS (TTM)
$14.63
राजस्व (TTM)
$4.60B
ROE (TTM)
22.1%
D/E ऋण/इक्विटी (MRQ)
0.9
52W रेंज
$129–$266
JAZZ स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
सीमा
बार
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
Jazz Pharmaceuticals plc - Ordinary Shares के बारे में विकिपीडिया से कंपनी का अवलोकन
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.
In 2007, the company pled guilty to felony charges related to its illegal marketing of Xyrem for off-label use.
The company is also a member of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Company history and acquisitions
2010–2019
On 18 February 2010, the FDA accepted a new drug application for JZP-6 (Sodium oxybate) for the treatment of Fibromyalgia. In the following December, a new patent was issued for Sodium Oxybate.
On September 19, 2011, Jazz Pharmaceuticals merged with Irish Azur Pharma plc to form Jazz Pharmaceuticals plc. The Azur Pharma seat in Dublin became the headquarters of the combined company. Azur Pharma had been marketing specialty pharmaceutical products in the central nervous system (CNS) and women's health areas with US operations in Philadelphia.
On 26 April 2012, the company acquired EUSA Pharma for $650 million (plus $50 million in milestone payments). In September, the company sold its Women's Health business to Meda for $95 million. In December, the company began clinical trial of intravenous Erwinaze in patients with Acute Lymphoblastic Leukemia.
In January 2014, the company announced it would acquire the rare disease drug developer Gentium SpA and its lead product Defitelio for $1 billion.
In May 2016, the company announced it would acquire Alizé Pharma II for $20.5 million. At the end of the same month, the company announced its then largest acquisition, with the purchase of Celator Pharmaceuticals for $1.5 billion. As a result, Jazz obtained the rights to breakthrough therapy Vyxeos (liposomal daunorubicin and cytarabine) for treatment of acute myeloid leukemia.
In August 2019, the company announced it would acquire Cavion Inc. for up to $310 million.
2020–present
In January 2021, Jazz announced it would acquire cannabis-focused medicinal drug company GW Pharmaceuticals for US$7.2 billion. This acquisition added the medication Epidiolex (cannabidiol), developed to treat severe epilepsy syndromes, to the company's portfolio.
In November 2025, Jazz Pharmaceuticals announced positive results from its Phase 3 trial for its cancer drug, Ziihera, a potential treatment for advanced gastroesophageal cancer.
Acquisition history
The following is an illustration of the company's mergers, acquisitions, spin-offs and historical predecessors:
== References ==
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
क्षेत्रHealthcare
उद्योगPharmaceuticals
कर्मचारी2890
देशIE
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व$4.27B2016-12-31 → 2025-12-31
EPS$-5.842016-12-31 → 2025-12-31
शुद्ध मार्जिन20.4%
मूल्यांकन और अनुपात
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | JAZZ | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E (TTM) | 16.15Y औसत ≈-12.5 | ≈-12.5 | · | · | |
| P/S (TTM) | 3.3 | · | · | · | |
| P/B (MRQ) | 3.2 | · | · | · | |
| मूल्य / FCF (TTM) | 9.6 | · | · | · | |
| मूल्य / नकदी प्रवाह (TTM) | 9.2 | · | · | · | |
| मूल्य / मूर्त पुस्तक (MRQ) | 19.8 | · | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | JAZZ | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| परिचालन मार्जिन (TTM) | 19.5% | · | · | · | |
| प्रीटैक्स मार्जिन (TTM) | 15.8% | · | · | · | |
| शुद्ध लाभ मार्जिन (TTM) | 20.4% | · | · | · | |
| ROA (TTM) | 8.5% | · | · | · | |
| ROE (TTM) | 22.1% | · | · | · |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | JAZZ | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| ऋण / इक्विटी (MRQ) | 0.9 | · | · | · | |
| वर्तमान अनुपात (MRQ) | 1.8 | · | · | · | |
| दीर्घकालिक ऋण / इक्विटी (MRQ) | 0.7 | · | · | · |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | JAZZ | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | 4.9%5Y औसत ≈13.0% | ≈13.0% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | 5.3%5Y औसत ≈10.8% | ≈10.8% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | 12.5% | · | · | · | |
| EPS YoY | 41.8% | · | · | · | |
| Net Income YoY (शुद्ध आय YoY) | 35.0% | · | · | · | |
| EPS CAGR 3Y | 13.1% | · | · | · | |
| Net Income CAGR 3Y (शुद्ध आय CAGR 3Y) | 20.2% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | JAZZ | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$1.5M | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
-1.6%
अगली रिपोर्ट
नव 03, 2026
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | अग 3, 2026 | $5.71 | $6.30 | -9.4% |
| 31 मार्च 2026 | $6.34 | $4.66 | 36.1% | |
| 31 दिसमबर 2025 | $6.64 | $6.65 | -0.11% | |
| 30 सितमबर 2025 | $8.13 | $6.04 | 34.7% | |
| 30 जून 2025 | $-8.25 | $-7.76 | -6.4% | |
| 31 मार्च 2025 | $1.68 | $4.75 | -64.6% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| R&D Expense | · | · | · | · | · | · | $300M | $227M | $198M | $162M | $135M | $85M | |
| SG&A Expense | $1.81B | $1.39B | $1.34B | $1.42B | $1.45B | $854M | $737M | $684M | $544M | $503M | $449M | $406M | |
| Operating Expenses | $4.70B | $3.35B | $3.26B | $3.72B | $2.92B | $1.99B | $1.63B | $1.28B | $1.09B | $896M | $817M | $977M | |
| Operating Income | $-430M | $717M | $579M | $-66M | $170M | $378M | $532M | $615M | $529M | $592M | $508M | $196M | |
| Interest Income | $86M | $106M | $65M | $12M | $2M | $11M | $20M | $17M | $4M | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $1M | $9M | |
| Pretax Income | $-628M | $470M | $298M | $-373M | $-113M | $275M | $454M | $529M | $441M | $532M | $436M | $152M | |
| Income Tax | $-272M | $-91M | $-120M | $-159M | $216M | $34M | $-73M | $80M | $-48M | $135M | $106M | $94M | |
| Net Income | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| EPS (Basic) | $-5.84 | $9.06 | $6.55 | $-3.58 | $-5.52 | $4.28 | $9.22 | $7.45 | $8.13 | $6.56 | $5.38 | $0.98 | |
| EPS (Diluted) | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 | $4.22 | $9.09 | $7.30 | $7.96 | $6.41 | $5.23 | $0.93 | |
| Shares (Basic) | 60,981,000 | 61,838,000 | 63,291,000 | 62,539,000 | 59,694,000 | 55,712,000 | 56,749,000 | 59,976,000 | 60,018,000 | 60,500,000 | 61,232,000 | 59,746,000 | |
| Shares (Diluted) | 60,981,000 | 66,007,000 | 72,066,000 | 62,539,000 | 59,694,000 | 56,517,000 | 57,550,000 | 61,221,000 | 61,317,000 | 61,870,000 | 63,036,000 | 62,614,000 |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.39B | $2.41B | $1.51B | $881M | $591M | $1.06B | $637M | $310M | $386M | $366M | $989M | $684M | |
| Receivables | $831M | $717M | $706M | $651M | $563M | $396M | $356M | $264M | $224M | $234M | $210M | $186M | |
| Inventory | $417M | $480M | $597M | $714M | $1.07B | $95M | $79M | $53M | $43M | $34M | $19M | $30M | |
| Prepaid Expense | $152M | $177M | $185M | $92M | $131M | $62M | $39M | $25M | $23M | $25M | $21M | $13M | |
| Other Current Assets | $324M | $262M | $321M | $267M | $252M | $152M | $79M | $68M | $77M | $29M | $19M | $21M | |
| Current Assets | $4.17B | $4.63B | $3.44B | $2.61B | $2.61B | $2.84B | $1.63B | $1.23B | $968M | $748M | $1.26B | $1.02B | |
| PP&E (Net) | · | · | · | · | · | $128M | $132M | $200M | $170M | $107M | $86M | $58M | |
| PP&E (Gross) | · | · | · | · | · | $196M | $187M | $250M | $211M | $140M | $109M | $74M | |
| Accum. Depreciation | · | · | · | · | · | $68M | $55M | $50M | $41M | $32M | $24M | $15M | |
| Goodwill | $1.83B | $1.72B | $1.75B | $1.69B | $1.83B | $958M | $920M | $928M | $948M | $894M | $657M | $703M | |
| Intangibles | $4.43B | $4.76B | $5.42B | $5.79B | $7.15B | $2.20B | $2.44B | $2.73B | $2.98B | $3.01B | $1.19B | $1.44B | |
| Other Non-current Assets | $99M | $114M | $67M | $55M | $41M | $26M | $48M | $43M | $16M | $14M | $9M | $16M | |
| Total Assets | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Accounts Payable | $122M | $78M | $103M | $91M | $100M | $27M | $46M | $41M | $24M | $22M | $22M | $25M | |
| Accrued Liabilities | $1.03B | $911M | $794M | $803M | $666M | $353M | $270M | $265M | $199M | $193M | $164M | $164M | |
| Current Liabilities | $2.24B | $1.04B | $1.54B | $933M | $809M | $654M | $364M | $345M | $294M | $257M | $227M | $217M | |
| Capital Leases | $51M | $39M | $59M | $72M | $87M | $140M | $151M | $0 | · | · | · | · | |
| Deferred Tax | $594M | $677M | $848M | $944M | $1.30B | $130M | $224M | $309M | $383M | $557M | $283M | $375M | |
| Other Non-current Liabilities | $124M | $87M | $105M | $107M | $117M | $101M | $109M | $219M | $177M | $113M | $69M | $38M | |
| Long-term Debt | $5.36B | $6.11B | $5.71B | $5.72B | $6.05B | $2.09B | $1.61B | $1.60B | $1.58B | $2.03B | $1.19B | $1.34B | |
| Common Stock | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Retained Earnings | $646M | $1.13B | $879M | $734M | $830M | $1.16B | $1.07B | $841M | $918M | $529M | $303M | $35M | |
| AOCI | $-569M | $-948M | $-842M | $-1.13B | $-400M | $-134M | $-223M | $-198M | $-141M | $-317M | $-267M | $-122M | |
| Stockholders' Equity | $4.32B | $4.09B | $3.74B | $3.09B | $3.97B | $3.66B | $3.11B | $2.76B | $2.71B | $1.88B | $1.71B | $1.37B | |
| Liabilities + Equity | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Shares Outstanding | 61,400,000 | 60,600,000 | 62,255,000 | 63,214,000 | 61,633,000 | 56,171,000 | 56,140,000 | 57,704,000 | 58,898,000 | 59,820,000 | 61,305,000 | 60,643,000 |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $33M | $30M | $30M | $27M | $19M | $15M | $15M | $13M | $12M | $10M | · | |
| Stock-based Comp | $291M | $248M | $227M | $222M | $189M | $121M | $111M | $102M | $107M | $99M | $92M | $70M | |
| Deferred Tax | $-445M | $-208M | $-260M | $-292M | $69M | $-137M | $-237M | $-89M | $-226M | $-41M | $-68M | $-49M | |
| Amort. of Intangibles | $655M | $627M | $608M | $599M | $526M | $260M | $355M | $201M | $152M | $102M | $98M | $127M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $2M | $2M | |
| Operating Cash Flow | $1.36B | $1.40B | $1.09B | $1.27B | $779M | $900M | $776M | $799M | $693M | $592M | $532M | $408M | |
| CapEx | $59M | $38M | $24M | $29M | $28M | $15M | $40M | $20M | $29M | $10M | $36M | $36M | |
| Investing Cash Flow | $-1.51B | $-508M | $-163M | $-446M | $-5.21B | $-1.01B | $-155M | $-394M | $-269M | $-1.75B | $-2M | $-1.07B | |
| Stock Repurchased | $125M | $311M | $270M | $54.0K | $0 | $147M | $301M | $524M | $99M | $278M | $62M | $42M | |
| Financing Cash Flow | $-873M | $21M | $-305M | $-529M | $3.97B | $528M | $-294M | $-479M | $-409M | $541M | $-214M | $711M | |
| Net Change in Cash | $-1.02B | $907M | $625M | $290M | $-466M | $420M | $328M | $-76M | $20M | $-623M | $305M | $48M | |
| Taxes Paid | $122M | $115M | $178M | · | · | · | · | · | · | · | · | · |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 | $4.22 | $9.09 | $7.30 | $7.96 | $6.41 | $5.23 | $0.93 |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.9% | 6.1% | 4.8% | 18.3% | 30.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.3% | 9.6% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 12.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 41.8% | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | · | 13.1% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | 35.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | · | 20.2% | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| Net Income TTM | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| P/E | -29.1 | 14.2 | 20.2 | -44.5 | -23.1 | 39.1 | 16.4 | 17.0 | 16.9 | 17.0 | 26.9 | 176.1 | |
| P / Tangible Book | · | · | · | · | · | 18.3 | · | · | · | · | · | · | |
| Earnings Yield | -3.4% | 7.0% | 5.0% | -2.2% | -4.3% | 2.6% | 6.1% | 5.9% | 5.9% | 5.9% | 3.7% | 0.57% |
आय विवरण
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.21B | $1.07B | $1.20B | $1.13B | $1.05B | $898M | $1.09B | $1.05B | $1.02B | $902M | $1.01B | $972M | $957M | $893M | $972M | $941M | |
| SG&A Expense | $389M | $353M | $406M | $531M | $358M | $514M | $369M | $326M | $339M | $352M | $396M | $308M | $341M | $298M | $383M | $358M | |
| Operating Expenses | $960M | $732M | $943M | $1.07B | $1.73B | $954M | $897M | $795M | $824M | $836M | $889M | $800M | $800M | $767M | $1.24B | $916M | |
| Operating Income | $248M | $337M | $255M | $58M | $-686M | $-56M | $191M | $260M | $199M | $66M | $122M | $172M | $158M | $126M | $-263M | $25M | |
| Interest Income | $25M | $23M | $20M | $19M | $19M | $28M | $32M | $26M | $25M | $23M | $21M | $19M | $15M | $11M | $7M | $4M | |
| Pretax Income | $211M | $299M | $208M | $9M | $-736M | $-110M | $133M | $201M | $138M | $-2M | $62M | $100M | $82M | $55M | $-340M | $-60M | |
| Income Tax | $18M | $6M | $5M | $-242M | $-17M | $-18M | $-58M | $-15M | $-31M | $12M | $-33M | $-47M | $-24M | $-15M | $-100M | $-43M | |
| Net Income | $193M | $293M | $203M | $251M | $-718M | $-92M | $191M | $215M | $169M | $-15M | $94M | $147M | $104M | $69M | $-241M | $-20M | |
| EPS (Basic) | $3.05 | $4.73 | $3.28 | $4.14 | $-11.74 | $-1.52 | $3.11 | $3.50 | $2.68 | $-0.23 | $1.50 | $2.33 | $1.63 | $1.09 | $-3.86 | $-0.31 | |
| EPS (Diluted) | $2.78 | $4.43 | $3.34 | $4.08 | $-11.74 | $-1.52 | $2.97 | $3.42 | $2.49 | $-0.23 | $1.40 | $2.14 | $1.52 | $1.04 | $-3.85 | $-0.31 | |
| Shares (Basic) | 63,200,000 | 61,900,000 | · | 60,696,000 | 61,200,000 | 61,000,000 | · | 61,414,000 | 62,882,000 | 62,537,000 | · | 63,114,000 | 63,991,000 | 63,494,000 | · | 62,785,000 | |
| Shares (Diluted) | 69,400,000 | 66,100,000 | · | 61,606,000 | 61,200,000 | 61,000,000 | · | 63,174,000 | 69,625,000 | 62,537,000 | · | 71,293,000 | 73,540,000 | 73,771,000 | · | 62,785,000 | |
| EBITDA | $248M | $337M | · | $58M | $-686M | $-56M | · | $260M | $199M | $66M | · | $172M | $158M | $126M | · | $25M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.62B | $1.84B | $1.39B | $1.33B | $1.19B | $1.86B | $2.41B | $2.22B | $1.36B | $1.44B | · | $1.34B | $1.28B | $1.17B | · | $839M | |
| Receivables | $881M | $836M | $831M | $764M | $714M | $653M | $717M | $724M | $698M | $707M | · | $628M | $610M | $624M | · | $601M | |
| Inventory | $443M | $438M | $417M | $483M | $505M | $493M | $480M | $539M | $543M | $577M | · | $612M | $657M | $675M | · | $728M | |
| Prepaid Expense | $200M | $150M | $152M | $147M | $164M | $150M | $177M | $155M | $134M | $123M | · | $110M | $107M | $73M | · | $93M | |
| Other Current Assets | $244M | $285M | $324M | $315M | $298M | $260M | $262M | $354M | $326M | $315M | · | $310M | $272M | $245M | · | $250M | |
| Current Assets | $3.97B | $4.58B | $4.17B | $3.76B | $3.35B | $4.13B | $4.63B | $4.39B | $3.68B | $3.54B | · | $3.25B | $3.01B | $2.78B | · | $2.57B | |
| Goodwill | $1.80B | $1.80B | $1.83B | $1.83B | $1.84B | $1.76B | $1.72B | $1.80B | $1.74B | $1.74B | · | $1.71B | $1.74B | $1.72B | · | $1.59B | |
| Intangibles | $4.03B | $4.20B | $4.43B | $4.57B | $4.77B | $4.72B | $4.76B | $5.14B | $5.08B | $5.24B | · | $5.42B | $5.71B | $5.76B | · | $5.57B | |
| Other Non-current Assets | $86M | $95M | $99M | $103M | $121M | $117M | $114M | $75M | $71M | $71M | · | $76M | $66M | $64M | · | $35M | |
| Total Assets | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Accounts Payable | $128M | $100M | $122M | $152M | $89M | $96M | $78M | $85M | $97M | $81M | · | $110M | $98M | $125M | · | $102M | |
| Accrued Liabilities | $1.03B | $1.02B | $1.03B | $1.00B | $875M | $1.06B | $911M | $859M | $801M | $827M | · | $770M | $748M | $712M | · | $668M | |
| Current Liabilities | $2.23B | $2.25B | $2.24B | $2.27B | $2.07B | $1.22B | $1.04B | $1.03B | $1.56B | $1.56B | · | $1.57B | $945M | $909M | · | $813M | |
| Capital Leases | $44M | $47M | $51M | $53M | $55M | $39M | $39M | $71M | $68M | $56M | · | $62M | $66M | $72M | · | $73M | |
| Deferred Tax | $529M | $548M | $594M | $629M | $682M | $671M | $677M | $792M | $775M | $810M | · | $841M | $911M | $932M | · | $934M | |
| Other Non-current Liabilities | $141M | $162M | $125M | $109M | $94M | $91M | $87M | $111M | $99M | $97M | · | $127M | $127M | $109M | · | $124M | |
| Long-term Debt | $4.35B | $5.35B | $5.36B | $5.36B | $5.36B | $5.37B | $6.11B | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Total Debt | $4.35B | $5.35B | · | $5.36B | $5.36B | $5.37B | · | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Common Stock | $0 | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $1.13B | $939M | $646M | $443M | $191M | $1.03B | $1.13B | $936M | $871M | $864M | · | $884M | $812M | $803M | · | $974M | |
| AOCI | $-662M | $-651M | $-569M | $-570M | $-486M | $-786M | $-948M | $-603M | $-888M | $-882M | · | $-1.04B | $-867M | $-980M | · | $-1.62B | |
| Stockholders' Equity | $4.80B | $4.53B | $4.32B | $3.96B | $3.71B | $4.17B | $4.09B | $4.17B | $3.76B | $3.70B | $3.74B | $3.49B | $3.53B | $3.34B | $3.09B | $2.75B | |
| Liabilities + Equity | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Shares Outstanding | 64,800,000 | 62,700,000 | 61,435,000 | 60,740,000 | 60,640,000 | 61,623,000 | 60,631,000 | 60,443,000 | 61,745,000 | 63,028,000 | 62,255,000 | 62,945,000 | · | · | 63,214,000 | · |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $73M | $74M | $71M | $88M | $65M | $68M | $70M | $60M | $57M | $61M | $53M | $56M | $61M | $56M | $62M | $57M | |
| Deferred Tax | $-39M | $-66M | $-63M | $-271M | $-66M | $-44M | $-2M | $-64M | $-75M | $-66M | $-36M | $-79M | $-79M | $-66M | $-145M | $-65M | |
| Amort. of Intangibles | $170M | $172M | $170M | $168M | $162M | $154M | $159M | $157M | $155M | $156M | $152M | $155M | $152M | $150M | $137M | $141M | |
| Operating Cash Flow | $416M | $408M | $363M | $475M | $89M | $430M | $399M | $399M | $331M | $267M | $167M | $307M | $297M | $321M | $342M | $418M | |
| CapEx | $18M | $20M | $17M | $15M | $13M | $14M | $13M | $11M | $7M | $7M | $10M | $4M | $6M | $4M | $9M | $-5M | |
| Investing Cash Flow | $355M | $123M | $-372M | $-328M | $-641M | $-169M | $-193M | $214M | $-257M | $-272M | $102M | $-174M | $-86M | $-5M | $-324M | $5M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $150M | · | · | $100M | $74M | · | · | $0 | $0 | |
| Financing Cash Flow | $-994M | $-78M | $75M | $-11M | $-125M | $-814M | $-8M | $246M | $-161M | $-57M | $-100M | $-78M | $-97M | $-30M | $20M | $-289M | |
| Net Change in Cash | $-224M | $452M | $66M | $136M | $-672M | $-551M | $195M | $862M | $-88M | $-63M | $171M | $53M | $114M | $286M | $42M | $128M | |
| Free Cash Flow | · | $388M | · | · | · | $416M | · | · | · | $260M | · | · | · | $317M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| Net Margin | 16.0% | 27.4% | · | 22.3% | -68.7% | -10.3% | · | 20.4% | 16.5% | -1.6% | · | 15.1% | 10.9% | 7.8% | · | -2.1% | |
| Pretax Margin | 17.5% | 28.0% | · | 0.80% | -70.3% | -12.2% | · | 19.0% | 13.5% | -0.18% | · | 10.2% | 8.5% | 6.2% | · | -6.4% | |
| EBITDA Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| ROA | 1.8% | 2.5% | · | 2.1% | -6.4% | -0.81% | · | 1.8% | 1.5% | -0.13% | · | 1.4% | 0.93% | 0.61% | · | -0.17% | |
| ROE | 4.5% | 6.7% | · | 6.2% | -19.2% | -2.4% | · | 5.6% | 4.6% | -0.42% | · | 4.7% | 3.1% | 2.0% | · | -0.59% | |
| ROIC | 2.5% | 3.3% | · | 17.2% | -7.4% | -0.49% | · | 2.7% | 2.6% | 5.8% | · | 2.8% | 2.2% | 1.8% | · | 0.08% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 2.0 | · | 1.7 | 1.6 | 3.4 | · | 4.3 | 2.4 | 2.3 | · | 2.1 | 3.2 | 3.1 | · | 3.2 | |
| Quick Ratio | 1.1 | 1.2 | · | 0.9 | 0.9 | 2.1 | · | 2.9 | 1.3 | 1.4 | · | 1.2 | 2.0 | 2.0 | · | 1.8 | |
| Debt / Equity | 0.9 | 1.2 | · | 1.4 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.7 | · | 2.1 | |
| LT Debt / Equity | 0.7 | 1.0 | · | 1.1 | 1.2 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.7 | · | 2.1 |
दक्षता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.3 | · | 1.6 | 1.6 | 1.4 | · | 1.6 | 1.6 | 1.5 | · | 1.7 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $74.10 | $72.29 | · | $65.18 | $61.12 | $67.75 | · | $69.01 | $60.94 | $58.65 | · | $55.44 | · | · | · | · | |
| Revenue / Share | $17.41 | $16.17 | · | $18.28 | $17.09 | $14.72 | · | $16.70 | $14.70 | $14.42 | · | $13.64 | $13.02 | $12.10 | · | $14.98 | |
| Cash Flow / Share | · | $6.18 | · | · | · | $7.05 | · | · | · | $4.27 | · | · | · | $4.35 | · | · | |
| Cash / Share | $25.00 | $29.41 | · | $21.83 | $19.62 | $30.22 | · | $36.70 | $21.96 | $22.90 | · | $21.22 | · | · | · | · | |
| EPS (TTM) | $14.63 | $0.11 | · | $-6.21 | $-6.87 | $7.36 | · | $7.08 | $5.80 | $4.83 | · | $0.85 | $-1.60 | $-2.57 | · | $-0.37 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.60B | $4.44B | · | $4.16B | $4.09B | $4.06B | · | $3.99B | $3.91B | $3.84B | · | $3.79B | $3.76B | $3.74B | · | $3.58B | |
| Net Income TTM | $941M | $29M | · | $-368M | $-405M | $482M | · | $463M | $395M | $331M | · | $80M | $-87M | $-156M | · | $-19M | |
| Market Cap | $15.61B | $11.85B | · | $8.01B | $6.44B | $7.65B | · | $6.73B | $6.59B | $7.59B | · | $8.15B | · | · | · | · | |
| Enterprise Value | $18.35B | $15.36B | · | $12.04B | $10.61B | $11.16B | · | $10.63B | $10.94B | $11.86B | · | $12.53B | · | · | · | · | |
| P/E | 16.5 | 1718.6 | · | -21.2 | -15.4 | 16.9 | · | 15.7 | 18.4 | 24.9 | · | 152.3 | -77.5 | -56.9 | · | -360.2 | |
| P/S | 3.4 | 2.7 | · | 1.9 | 1.6 | 1.9 | · | 1.7 | 1.7 | 2.0 | · | 2.1 | · | · | · | · | |
| P/B | 3.3 | 2.6 | · | 2.0 | 1.7 | 1.8 | · | 1.6 | 1.8 | 2.1 | · | 2.3 | · | · | · | · | |
| P / Cash Flow | · | 29.0 | · | · | · | 17.8 | · | · | · | 28.4 | · | · | · | · | · | · | |
| EV / Revenue | 4.0 | 3.5 | · | 2.9 | 2.6 | 2.7 | · | 2.7 | 2.8 | 3.1 | · | 3.3 | · | · | · | · | |
| Earnings Yield | 6.1% | 0.06% | · | -4.7% | -6.5% | 5.9% | · | 6.3% | 5.4% | 4.0% | · | 0.66% | -1.3% | -1.8% | · | -0.28% |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| राजस्व | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B |
| शुद्ध आय | $-356M | $560M | $415M | $-224M | $-330M |
| तनुकरणित EPS | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 |
इस स्टेटमेंट के लिए कोई डेटा नहीं
इस स्टेटमेंट को बनाने के लिए अभी पर्याप्त फंडामेंटल्स डेटा नहीं है।
इस स्टेटमेंट के लिए कोई डेटा नहीं
इस स्टेटमेंट को बनाने के लिए अभी पर्याप्त फंडामेंटल्स डेटा नहीं है।
संस्थागत मालिक (13F) 687 फाइलर्स · $15.8B कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
धारक
687
धारित मूल्य
$15.8B
नई स्थितियाँ
138
बाहर निकली पोजीशन
56
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 138 (+32 पिछली तिमाही की तुलना में) | 56 (-21 पिछली तिमाही की तुलना में) | 240 (+24 पिछली तिमाही की तुलना में) | 188 (+19 पिछली तिमाही की तुलना में) | +942K |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| BlackRock, Inc. | $1438254453 | 5968603 | 9.11% | शेयर |
| FMR LLC | $1110709035 | 4609326 | 7.04% | शेयर |
| VANGUARD GROUP INC | $1005914140 | 5917142 | 6.37% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $731636247 | 3036213 | 4.64% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $657763761 | 2729650 | 4.17% | शेयर |
| Capital World Investors | $650043082 | 2697610 | 4.12% | शेयर |
| FRANKLIN RESOURCES INC | $491639148 | 2040250 | 3.12% | शेयर |
| STATE STREET CORP | $481895662 | 1999816 | 3.05% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $412909300 | 1713592 | 2.62% | शेयर |
| FULLER & THALER ASSET MANAGEMENT, INC. | $394839917 | 1638544 | 2.50% | शेयर |
| Bank of New York Mellon Corp | $380253849 | 1578013 | 2.41% | शेयर |
| AQR CAPITAL MANAGEMENT LLC | $359935093 | 1522568 | 2.28% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $357440125 | 1483031 | 2.26% | शेयर |
| AMERIPRISE FINANCIAL INC | $292895571 | 1215523 | 1.86% | शेयर |
| JPMORGAN CHASE & CO | $276634191 | 1160786 | 1.75% | शेयर |
| BANK OF AMERICA CORP /DE/ | $273763940 | 1136091 | 1.73% | शेयर |
| CITADEL ADVISORS LLC | $242578716 | 1006676 | 1.54% | शेयर |
| Swedbank AB | $233281128 | 968092 | 1.48% | शेयर |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $192606598 | 799297 | 1.22% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $184072164 | 763880 | 1.17% | शेयर |
| UBS Group AG | $182381760 | 756865 | 1.16% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $165478678 | 686719 | 1.05% | शेयर |
| NORGES BANK | $158279458 | 656843 | 1.00% | शेयर |
| MORGAN STANLEY | $151734512 | 629680 | 0.96% | शेयर |
| Mariner, LLC | $146630968 | 608615 | 0.93% | शेयर |
| RENAISSANCE TECHNOLOGIES LLC | $135442731 | 562073 | 0.86% | शेयर |
| Allianz Asset Management GmbH | $131345759 | 545071 | 0.83% | शेयर |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $129891746 | 539037 | 0.82% | शेयर |
| NORTHERN TRUST CORP | $123222660 | 511361 | 0.78% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $111450794 | 462509 | 0.71% | शेयर |
| GMT Capital Corp | $109279895 | 453500 | 0.69% | शेयर |
| Boston Trust Walden Corp | $106779349 | 443123 | 0.68% | शेयर |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $105278106 | 436893 | 0.67% | शेयर |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $103893734 | 431148 | 0.66% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $96439086 | 400212 | 0.61% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $95008929 | 394277 | 0.60% | शेयर |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $91259201 | 378715 | 0.58% | शेयर |
| Nuveen, LLC | $88051524 | 365405 | 0.56% | शेयर |
| Sofinnova Investments, Inc. | $88036221 | 365341 | 0.56% | शेयर |
| Polaris Capital Management, LLC | $79270937 | 328966 | 0.50% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $77695234 | 322427 | 0.49% | शेयर |
| GOLDENTREE ASSET MANAGEMENT LP | $70838675 | 294435 | 0.45% | शेयर |
| Qube Research & Technologies Ltd | $70056003 | 290725 | 0.44% | शेयर |
| GOLDMAN SACHS GROUP INC | $67434009 | 279844 | 0.43% | शेयर |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $66815854 | 277279 | 0.42% | शेयर |
| Quantinno Capital Management LP | $65906960 | 273506 | 0.42% | शेयर |
| BANK OF MONTREAL /CAN/ | $58329921 | 242063 | 0.37% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $55096752 | 228645 | 0.35% | शेयर |
| Tri Locum Partners LP | $53427868 | 221720 | 0.34% | शेयर |
| Invesco Ltd. | $50427310 | 209268 | 0.32% | शेयर |
कार्यकर्ता और 5%+ मालिक 6 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals Public Limited Company, Jazz Financing I Limited, Jazz Investments II Limited, Jazz Pharmaceuticals Italy S.p.A. ×4 फाइलिंग | 20 जून 2014 | · | प्रारंभिक फाइलिंग | · | SEC |
| KKR JP LLC, KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, KKR JP III LLC, KKR Partners III, L.P., KKR III GP LLC, Henry R. Kravis, George R. Roberts ×3 फाइलिंग | 12 मार्च 2013 | · | प्रारंभिक फाइलिंग | · | SEC |
| Longitude Capital Partners, LLC, Longitude Venture Partners, L.P., Longitude Capital Associates, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×3 फाइलिंग | 14 मार्च 2012 | · | प्रारंभिक फाइलिंग | पूंजी संरचना | SEC |
| Longitude Capital Partners, LLC (2), Longitude Venture Partners, L.P. (2), Longitude Capital Associates, L.P. (2), Patrick G. Enright (2), Juliet Tammenoms Bakker (2) ×3 फाइलिंग | 30 सितमबर 2011 | · | प्रारंभिक फाइलिंग | · | SEC |
| Azur Pharma Limited | 28 सितमबर 2011 | · | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
| Jazz Pharmaceuticals, Inc., KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Partners III, L.P., KKR III GP LLC, KKR JP LLC, KKR JP III LLC | 28 अप्रैल 2005 | · | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 56 इनसाइडर्स · 18 अधिकारी · 20 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Renee D Gala | President & CEO | 8 सितमबर 2026 S | 143394 | 0 | 1 | $-486060 |
| Philip L Johnson | EVP & Chief Financial Officer | 30 जून 2026 F | 56431 | 0 | 0 | $0 |
| Matthew P. Young | EVP & CFO | 6 मार्च 2019 S | 36200 | 0 | 0 | $0 |
| Daniel N Swisher JR | President and COO | 5 मार्च 2023 F | 55014 | 0 | 0 | $0 |
| Christopher J. Tovey | EVP, COO & Managing Director E | 5 जुलाई 2022 M | 14663 | 0 | 0 | $0 |
| Russell J. Cox | EVP & COO | 11 दिसमबर 2017 M | 102821 | 0 | 0 | $0 |
| Neena M Patil | EVP & Chief Legal Officer | 10 सितमबर 2026 S | 47671 | 0 | 14 | $-11500359 |
| Mary Elizabeth Henderson | SVP, Technical Operations | 8 सितमबर 2026 F | 23815 | 0 | 2 | $-1418523 |
| Robert Iannone | EVP, Global Head of R&D & CMO | 27 अगस्त 2026 M | 65686 | 0 | 7 | $-20411738 |
| Samantha Pearce | EVP, Chief Commercial Officer | 5 अगस्त 2026 F | 47131 | 0 | 1 | $-1625977 |
| Patricia Carr | SVP, Chief Accounting Officer | 9 मार्च 2026 S | 6512 | 0 | 7 | $-2458091 |
| Kim Sablich | EVP, GM of U.S. | 5 जून 2023 D | 28478 | 0 | 0 | $0 |
| Finbar Larkin | SVP, Technical Operations | 6 मार्च 2023 M | 21779 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | EVP, US Commercial | 12 मार्च 2020 S | 22118 | 0 | 0 | $0 |
| Paul Treacy | SVP, Technical Operations | 12 अगस्त 2019 S | 16418 | 0 | 0 | $0 |
| Iain Mcgill | SVP, Europe & Rest of World | 5 मार्च 2019 F | 24938 | 0 | 0 | $0 |
| Karen J Wilson | SVP, Finance & PAO | 5 मार्च 2019 F | 18385 | 0 | 0 | $0 |
| Suzanne Sawochka Hooper | EVP & General Counsel | 27 फ़रवरी 2019 M | 39738 | 0 | 0 | $0 |
| Bruce C Cozadd | निदेशक | 1 सितमबर 2026 S | 351875 | 0 | 21 | $-27147106 |
| Patrick Kennedy | निदेशक | 31 अगस्त 2026 F | 6452 | 0 | 0 | $0 |
| Mark Douglas Smith | निदेशक | 31 अगस्त 2026 F | 9579 | 0 | 1 | $-266746 |
| Jennifer E. Cook | निदेशक | 31 अगस्त 2026 F | 10736 | 0 | 0 | $0 |
| Laura Hamill | निदेशक | 31 अगस्त 2026 F | 6832 | 0 | 0 | $0 |
| Heather Ann Mcsharry | निदेशक | 31 अगस्त 2026 F | 18199 | 0 | 2 | $-1089119 |
| Rick E Winningham | निदेशक | 31 अगस्त 2026 F | 9466 | 0 | 2 | $-1656873 |
| Patrick G. Enright | निदेशक | 31 अगस्त 2026 F | 21278 | 0 | 0 | $0 |
| Ted W Love | निदेशक | 31 अगस्त 2026 F | 2389 | 0 | 0 | $0 |
| Norbert G Riedel | निदेशक | 31 अगस्त 2026 F | 6923 | 0 | 1 | $-655680 |
| Seamus Mulligan | निदेशक | 5 अगस्त 2026 A | 1184633 | 0 | 0 | $0 |
| Anne Oriordan | निदेशक | 8 अगस्त 2025 F | 16500 | 0 | 0 | $0 |
| Peter Gray | निदेशक | 14 अगस्त 2023 S | 16068 | 0 | 0 | $0 |
| Catherine A. Sohn | निदेशक | 14 अगस्त 2023 S | 14868 | 0 | 0 | $0 |
| Elmar Schnee | निदेशक | 5 अगस्त 2021 S | 8270 | 0 | 0 | $0 |
| Paul L Berns | निदेशक | 5 अगस्त 2021 S | 8290 | 0 | 0 | $0 |
| Bryan C Cressey | निदेशक | 9 मार्च 2012 S | 27631 | 0 | 0 | $0 |
| Zilkha M Nathaniel | निदेशक | 10 मार्च 2011 A | · | 0 | 0 | $0 |
| Alexander E Albert | निदेशक | 15 अगस्त 2008 A | · | 0 | 0 | $0 |
| Patel Jaimin | निदेशक | 15 अगस्त 2007 A | · | 0 | 0 | $0 |
| Kenneth W O'Keefe | · | 2 दिसमबर 2025 F | 25811 | 0 | 0 | $0 |
| Karen L. Smith | · | 5 मार्च 2018 F | 28474 | 0 | 0 | $0 |
| Jeffrey K Tobias | · | 5 मार्च 2015 F | 38484 | 0 | 0 | $0 |
| Fintan Keegan | · | 8 जुलाई 2014 M | 31750 | 0 | 0 | $0 |
| Kathryn E Falberg | · | 5 मार्च 2014 F | 133387 | 0 | 0 | $0 |
| James C Momtazee | · | 13 अगस्त 2013 S | 17315 | 0 | 0 | $0 |
| Carol A Gamble | · | 9 मार्च 2012 S | 32213 | 0 | 0 | $0 |
| Alan Sebulsky | · | 9 मार्च 2012 S | 54355 | 0 | 0 | $0 |
| Samuel D Colella | · | 11 जनवरी 2012 M | 38347 | 0 | 0 | $0 |
| Michael W Michelson | · | 11 जनवरी 2012 M | 13885 | 0 | 0 | $0 |
| Mark G. Eller | · | 13 अगस्त 2011 M | 4151 | 0 | 0 | $0 |
| Michael A. Desjardin | · | 13 अगस्त 2011 M | 14574 | 0 | 0 | $0 |
| Janne Lt Wissel | · | 31 मई 2011 J | 48544 | 0 | 0 | $0 |
| Joan Colligan | · | 30 नवमबर 2010 J | 14424 | 0 | 0 | $0 |
| Robert M Myers | · | 30 नवमबर 2010 J | 156898 | 0 | 0 | $0 |
| James B Tananbaum | · | 25 अगस्त 2010 A | 21366 | 0 | 0 | $0 |
| Samuel R Saks | · | 21 जनवरी 2009 A | 358868 | 0 | 0 | $0 |
| Matthew K Fust | · | 28 नवमबर 2008 J | 58948 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 62 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| IHE · iShares Trust | 3.45% | 232236 SH | 11 सितमबर 2026 | दैनिक |
| PJP · Invesco Exchange-Traded Fund Trust | 2.85% | 68707 SH | 1 अक्टूबर 2026 | दैनिक |
| XMMO · Invesco Exchange-Traded Fund Trust | 2.31% | 699006 SH | 1 अक्टूबर 2026 | दैनिक |
| PTH · Invesco Exchange-Traded Fund Trust | 1.69% | 26762 SH | 1 अक्टूबर 2026 | दैनिक |
| PILL · Direxion Shares ETF Trust | 1.25% | 1023 NS | 31 जुलाई 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.98% | 4592 SH | 1 अक्टूबर 2026 | दैनिक |
| RFG · Invesco Exchange-Traded Fund Trust | 0.96% | 13808 SH | 1 अक्टूबर 2026 | दैनिक |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.79% | 61910 SH | 19 अगस्त 2026 | दैनिक |
| PDP · Invesco Exchange-Traded Fund Trust | 0.58% | 36818 SH | 1 अक्टूबर 2026 | दैनिक |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0.58% | 14802 NS | 31 जुलाई 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0.54% | 27352 NS | 31 जुलाई 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0.49% | 8679 SH | 1 अक्टूबर 2026 | दैनिक |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.41% | 101353 SH | 19 अगस्त 2026 | दैनिक |
| MIDU · Direxion Shares ETF Trust | 0.34% | 921 NS | 31 जुलाई 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.32% | 11363 SH | 19 अगस्त 2026 | दैनिक |
| VBR · VANGUARD INDEX FUNDS | 0.31% | 867777 SH | 19 अगस्त 2026 | दैनिक |
| VFMF · VANGUARD WELLINGTON FUND | 0.28% | 8083 SH | 19 अगस्त 2026 | दैनिक |
| DFAS · Dimensional ETF Trust | 0.28% | 168574 NS | 31 जुलाई 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.24% | 19561 SH | 19 अगस्त 2026 | दैनिक |
| IYH · iShares Trust | 0.23% | 34871 SH | 11 सितमबर 2026 | दैनिक |
| ESML · iShares Trust | 0.22% | 25740 SH | 11 सितमबर 2026 | दैनिक |
| DFAT · Dimensional ETF Trust | 0.22% | 123193 NS | 31 जुलाई 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.20% | 166548 SH | 19 अगस्त 2026 | दैनिक |
| SMMD · iShares Trust | 0.20% | 31945 SH | 11 सितमबर 2026 | दैनिक |
| RWK · Invesco Exchange-Traded Fund Trust … | 0.18% | 9978 SH | 1 अक्टूबर 2026 | दैनिक |
| VXF · VANGUARD INDEX FUNDS | 0.17% | 719903 SH | 19 अगस्त 2026 | दैनिक |
| VB · VANGUARD INDEX FUNDS | 0.17% | 1366973 SH | 19 अगस्त 2026 | दैनिक |
| IWS · iShares Trust | 0.14% | 88598 SH | 11 सितमबर 2026 | दैनिक |
| WSML · iShares Trust | 0.13% | 3647 SH | 11 सितमबर 2026 | दैनिक |
| IWR · iShares Trust | 0.11% | 244305 SH | 11 सितमबर 2026 | दैनिक |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 3138 SH | 1 अक्टूबर 2026 | दैनिक |
| XT · iShares Trust | 0.09% | 13710 SH | 11 सितमबर 2026 | दैनिक |
| DFAC · Dimensional ETF Trust | 0.08% | 147012 NS | 31 जुलाई 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.08% | 45748 NS | 31 जुलाई 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.05% | 7084 NS | 31 जुलाई 2026 | N-PORT |
| IUSG · iShares Trust | 0.04% | 55258 SH | 11 सितमबर 2026 | दैनिक |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.04% | 36014 SH | 19 अगस्त 2026 | दैनिक |
| IWD · iShares Trust | 0.04% | 133301 SH | 11 सितमबर 2026 | दैनिक |
| DSI · iShares Trust | 0.04% | 8411 SH | 11 सितमबर 2026 | दैनिक |
| PRF · Invesco Exchange-Traded Fund Trust | 0.04% | 15040 SH | 1 अक्टूबर 2026 | दैनिक |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.03% | 1369 SH | 30 सितमबर 2026 | दैनिक |
| DFAU · Dimensional ETF Trust | 0.03% | 13729 NS | 31 जुलाई 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0.02% | 39438 SH | 11 सितमबर 2026 | दैनिक |
| DXUV · Dimensional ETF Trust | 0.02% | 467 NS | 31 जुलाई 2026 | N-PORT |
| IYY · iShares Trust | 0.02% | 2648 SH | 11 सितमबर 2026 | दैनिक |
| DFUS · Dimensional ETF Trust | 0.02% | 17349 NS | 31 जुलाई 2026 | N-PORT |
| ITOT · iShares Trust | 0.02% | 81293 SH | 11 सितमबर 2026 | दैनिक |
| IWB · iShares Trust | 0.02% | 41012 SH | 11 सितमबर 2026 | दैनिक |
| VTI · VANGUARD INDEX FUNDS | 0.02% | 1892855 SH | 19 अगस्त 2026 | दैनिक |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.02% | 9995 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.02% | 5021 SH | 19 अगस्त 2026 | दैनिक |
| ESGV · VANGUARD WORLD FUND | 0.02% | 13490 SH | 19 अगस्त 2026 | दैनिक |
| IWV · iShares Trust | 0.02% | 16075 SH | 10 सितमबर 2026 | दैनिक |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 49429 SH | 19 अगस्त 2026 | दैनिक |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.01% | 1238 SH | 1 अक्टूबर 2026 | दैनिक |
| NEAR · iShares U.S. ETF Trust | 0.00% | 200000 SH | 9 सितमबर 2026 | दैनिक |
| IJH · iShares Trust | · | 2201423 SH | 11 सितमबर 2026 | दैनिक |
| IJK · iShares Trust | · | 363871 SH | 11 सितमबर 2026 | दैनिक |
| XJH · iShares Trust | · | 8572 SH | 8 सितमबर 2026 | दैनिक |
| ISCB · iShares Trust | · | 2820 SH | 11 सितमबर 2026 | दैनिक |
| ISCV · iShares Trust | · | 13894 SH | 11 सितमबर 2026 | दैनिक |
| SMMV · iShares Trust | · | 4635 SH | 19 अगस्त 2026 | दैनिक |
JAZZ विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
रेटिंग · 26 विश्लेषक
खरीदें
मध्यिका लक्ष्य
$300.00
+27.3%
7 26.9%
मजबूत खरीद
17 65.4%
खरीदें
2 7.7%
होल्ड
0 0.0%
बेचें
0 0.0%
मजबूत बिक्री
12-महीने का मूल्य लक्ष्य
22 विश्लेषक · 2026-10-03माध्य लक्ष्य $294.27 +24.9%
अभी
वर्तमान मूल्य $235.67
निम्न$225.00
माध्य$294.27
उच्च$337.00
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
स्रोत: SEC 10-Q अग 3, 2026 को फाइल किया गया